Hematopoietic stem cell transplantation in a patient with type 1 mosaic variegated aneuploidy syndrome.

Alexandra Laberko Dmitry Balashov Elena Deripapa Olga Soldatkina Elena Raikina Alexey A Maschan Galina A Novichkova Anna Shcherbina

Published in: Orphanet journal of rare diseases (2019)

In conclusion, we demonstrate that RIC HSCT with TCRαβ+/CD19+ depletion was well tolerated and resulted in complete hematologic recovery in our MVA1 patient, but, unfortunately, it was followed by rapid graft rejection. This fact needs to be taken into consideration for HSCT in other MVA patients.

Keyphrases

case report
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
hematopoietic stem cell
patient reported outcomes
dendritic cells
sensitive detection